Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in human papillomavirus vaccines.

Peter L Stern1

  • 1Cancer Research UK Immunology Group, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 4BX, UK. pstern@picr.man.ac.uk

Expert Opinion on Investigational Drugs
|July 23, 2004
PubMed
Summary

Human papillomavirus (HPV) vaccines show promise in preventing infections and potentially cervical cancer. Future research will focus on long-term protection and therapeutic vaccine efficacy for widespread impact.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is immunotherapy a potential game changer in managing human papillomavirus (HPV) infection and intraepithelial neoplasia?

Tumour virus research·2023
Same author

Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors.

Viruses·2021
Same author

Harnessing immunity for therapy in human papillomavirus driven cancers.

Tumour virus research·2021
Same author

Welcome to Tumour Virus Research.

Tumour virus research·2021
Same author

Key steps in vaccine development.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2020
Same author

Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma.

British journal of cancer·2019

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • High-risk human papillomaviruses (HPVs) are linked to anogenital cancers.
  • Preclinical studies support HPV vaccine development for prevention and therapy.

Purpose of the Study:

  • To evaluate the efficacy of prophylactic and therapeutic HPV vaccines.
  • To explore combined vaccine strategies for reducing cervical cancer mortality.

Main Methods:

  • Prophylactic vaccines utilize L1 virus-like particles to generate neutralizing antibodies.
  • Therapeutic vaccines focus on T-cell responses against E6/E7 oncogenes.
  • Various vaccine platforms (peptide, protein, DNA, viral vector) are assessed.

Main Results:

Related Experiment Videos

  • HPV virus-like particle vaccines demonstrate clinical efficacy in preventing infections.
  • Therapeutic vaccines are safe and immunogenic but lack consistent clinical outcome correlation.
  • Early trials show promise for prophylactic HPV vaccines.

    • Conclusions:

    • Prophylactic HPV vaccines are effective in preventing infection.
    • Further milestones include demonstrating prevention of high-grade cervical intraepithelial neoplasia and long-term protection.
    • Combined prophylactic and therapeutic vaccines may significantly reduce global cervical cancer deaths.